Skip to Main Content

Nanoparticles, Fetal Therapy, & Pediatric Surgery - The Stitelman Lab at Yale School of Medicine

May 20, 2025

Transcript

  • 00:05The fetus is a fascinating patient.
  • 00:08They have many accessible and developing stem cell populations
  • 00:12that are gone once the baby is born.
  • 00:15Historically, if you do fetal surgery where you operate on a fetus,
  • 00:20the wound heals with no scar.
  • 00:22So it's a very different patient than even a baby.
  • 00:26And so the idea that you could get organs to grow more normally while they're
  • 00:32in the process of becoming the organs that they're going to be is compelling.
  • 00:40Our lab is looking at ways to
  • 00:43treat and cure genetic and structural diseases before birth.
  • 00:47The clinical practice in pediatric surgery
  • 00:50is babies who are born with a variety of needs.
  • 00:53So babies whose abdominal walls don't form normally
  • 00:57or diaphragms don't form normally
  • 00:58or lungs, guts and airways that don't form normally,
  • 01:01and some of these things are diagnosed before birth
  • 01:04and that's a window to allow the baby to develop normally,
  • 01:09if you can correct problem.
  • 01:15So our work is a collaboration with biomedical engineering
  • 01:18and molecular therapy at Yale,
  • 01:20and we deliver therapeutic agents in very small particles
  • 01:24to try to treat genetic or structural diseases before birth.
  • 01:28The first part of it is synthesizing those particles
  • 01:32using a variety of techniques to verify that they're good quality,
  • 01:36and that they are loaded with the things that you think that they're loaded with.
  • 01:40We're able to deliver those particles to fetuses in experimental models
  • 01:45and then there's one round of analysis, which is where are the particles going?
  • 01:50So that's typically microscopy or flow cytometry,
  • 01:54and then if you're trying to rescue a disease model then
  • 01:57the analysis depends on the model that you're looking.
  • 02:00They're projects where we're looking at lung growth,
  • 02:03techniques to to assess those are microscopy functional assays
  • 02:06and we've actually started to get into more sophisticated molecular techniques
  • 02:10like single cell RNA sequencing and spatialomics
  • 02:14where you can really try to understand
  • 02:16the interactions between the cells in normal fetal development,
  • 02:19and then the interactions of those cells when there's abnormal fetal development.
  • 02:27With the spectrum of things that we're working in the lab,
  • 02:30you could provide a single shot
  • 02:32that would cure a variety of genetic diseases.
  • 02:35So lysosomal storage diseases,
  • 02:38diseases of the brain, cystic fibrosis, blood diseases.
  • 02:41You may be able to have a single shot
  • 02:43and cure a genetic disease for the duration of that patient's lifetime.
  • 02:48Other strategies that are a little bit newer for our lab,
  • 02:5145% of neonatal death
  • 02:54is due to these issues of prematurity
  • 02:57and if you could improve the health and function of the tissues that support a healthy pregnancy,
  • 03:02then you may be able to drastically move the needle
  • 03:05on these sort of major public health problems.